Literature DB >> 10331572

Clear cell carcinoma arising in a Cesarean section scar endometriosis: a case report.

S W Park1, S M Hong, H G Wu, S W Ha.   

Abstract

Endometriosis of a surgical scar is rare and occurs mainly when a hysterectomy or Cesarean section was performed. We describe a 54-year-old woman with a large suprapubic mass as a definite case of a endomerioid carcinoma developing within the scar endometriosis following Cesarean section. Scar endometriosis, as well as endometriosis at other sites, can turn malignant. Endometrioid carcinoma is the most common histological pattern of malignant tumor arising in endometriosis. But clear cell carcinoma is very unusual. A case of primary clear cell carcinoma in endometriosis of a Cesarean section scar is described. To the best of our knowledge, this is the first documented case of endomerioid carcinoma developing within the scar endometriosis in Korea.

Entities:  

Mesh:

Year:  1999        PMID: 10331572      PMCID: PMC3054369          DOI: 10.3346/jkms.1999.14.2.217

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  11 in total

Review 1.  Endometriosis-associated Clear Cell Carcinoma of the Abdominal Wall After Caesarean Section: A Case Report and Review of the Literature.

Authors:  Luca Giannella; Matteo Serri; Elena Maccaroni; Jacopo DI Giuseppe; Giovanni Delli Carpini; Rossana Berardi; Francesco Sopracordevole; Andrea Ciavattini
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  A Rare Case of Episiotomy Scar Endometriosis.

Authors:  Shanti Jeyaseelan; Neha Kwatra
Journal:  J Obstet Gynaecol India       Date:  2015-12-17

3.  Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy.

Authors:  Stefanie Aust; Denise Tiringer; Christoph Grimm; Josefine Stani; Martin Langer
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

4.  Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass.

Authors:  Juan E Cuartas; Aditya V Maheshwari; Rabah Qadir; Andrew J Cooper; Philip G Robinson; J David Pitcher
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

5.  Clear cell carcinoma arising from cesarean section scar endometriosis: case report and review of the literature.

Authors:  Sakura Ijichi; Taisuke Mori; Izumi Suganuma; Takuro Yamamoto; Hiroshi Matsushima; Fumitake Ito; Makoto Akiyama; Izumi Kusuki; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-11-02

Review 6.  Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.

Authors:  Gabriella Ferrandina; Eleonora Palluzzi; Francesco Fanfani; Stefano Gentileschi; Anna Lia Valentini; Maria Vittoria Mattoli; Ilaria Pennacchia; Giovanni Scambia; Gianfranco Zannoni
Journal:  World J Surg Oncol       Date:  2016-12-03       Impact factor: 2.754

Review 7.  Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review.

Authors:  Anca Mihailovici; Misgav Rottenstreich; Svetlana Kovel; Ilan Wassermann; Noam Smorgick; Zvi Vaknin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Clear cell carcinoma arising from scar endometriosis: A case report and literature review.

Authors:  Chun-Jui Wei; Shu-Han Huang
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Jan-Mar

9.  Incisional carcinoma of Mullerian Origin: A case report and review of literature.

Authors:  Sabrina Bedell; Zenas Chang; Cassaundra Burt; Mahmoud A Khalifa; Peter A Argenta
Journal:  Gynecol Oncol Rep       Date:  2020-05-22

10.  Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic Surgeries: 15 Years of Experience at a Large Academic Institution.

Authors:  Yen-Ling Lai; Heng-Cheng Hsu; Kuan-Ting Kuo; Yu-Li Chen; Chi-An Chen; Wen-Fang Cheng
Journal:  Int J Environ Res Public Health       Date:  2019-02-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.